Head of Clinical AI Portfolio, Senior Director, AI for Clinical Development

Role: Senior strategic leader responsible for defining and owning AstraZeneca's AI portfolio in Clinical Development, spanning Phases I–III. Objectives include setting the AI strategy to maximize clinical value, prioritizing demands, building business cases, and demonstrating ROI. Responsibilities encompass portfolio governance, roadmap development, stakeholder engagement, and translating emerging AI methods into strategic initiatives. The role acts as a trusted adviser to senior leadership, integrating clinical, operational, and technical perspectives to accelerate clinical trial design, conduct, and analysis. Requirements: Bachelor's degree in life sciences, engineering, or related field; 8+ years in clinical R&D, informatics, or applied AI, with proven portfolio leadership and cross-functional program delivery. Skills include strategic planning, stakeholder management, clinical development lifecycle expertise, and familiarity with modern AI/ML (foundation models, LLMs). Preferred qualifications include experience embedding AI into clinical processes, vendor due diligence, change management, and hands-on clinical development. High-value biopharma specifics involve clinical Phases I–III, regulated environment considerations, and AI/ML solution evaluation. The role involves collaboration with research, clinical operations, biometrics, and regulatory teams, with a hybrid work setup and some travel expectations.